Condition: Supratentorial Hemorrhage · Sponsor: Integra LifeSciences Corporation
This registry will study the use of the Aurora® Surgiscope to provide surgical access and visualization in minimally invasive removal of hematoma in the brain. Many methods of hematoma removal are available and will be based on surgeon preference. The impact of patient selection and time to surgery from last known well time will be explored.
This description comes directly from the study's public registry record.
Habib Nacer-Chérif · +33626190029 · habib.nacercherif@integralife.com
Always discuss trial participation with your own doctor first.
| Providence Health | Burbank, California, United States | Recruiting |
| University of Miami | Miami, Florida, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Rush University Medical Center | Chicago, Illinois, United States | Recruiting |
| MedStar Health Research Institute | Baltimore, Maryland, United States | Not Yet Recruiting |
| Corewell Health | Grand Rapids, Michigan, United States | Terminated |
| University of Missouri | Columbia, Missouri, United States | Recruiting |
| Washington University in St. Louis | St Louis, Missouri, United States | Recruiting |
| JFK university | Edison, New Jersey, United States | Recruiting |
| University at Buffalo | Buffalo, New York, United States | Recruiting |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | Recruiting |
| University of North Carolina | Chapel Hill, North Carolina, United States | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04494295